AstraZeneca PLC
LSE-AZN
Basic
Market Cap
£188.82B
EV
£209.91B
Shares Out
1,550.27M
Revenue
$49.13B
Employees
89,900
Margins
Gross
82.62%
EBITDA
34.55%
Operating
25.13%
Pre-Tax
15.77%
Net
13.11%
FCF
19.18%
Returns (5Yr Avg)
ROA
3.67%
ROTA
-204.57%
ROE
12.68%
ROCE
10.32%
ROIC
8.24%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
£139.82
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,076M
Net Debt
$26.57B
Debt/Equity
0.85
EBIT/Interest
9.65
Growth (CAGR)
Rev 3Yr
18.5%
Rev 5Yr
16.32%
Rev 10Yr
6.44%
Dil EPS 3Yr
12.79%
Dil EPS 5Yr
19.2%
Dil EPS 10Yr
9.9%
Rev Fwd 2Yr
10.07%
EBITDA Fwd 2Yr
25.87%
EPS Fwd 2Yr
13.23%
EPS LT Growth Est
13.45%
Dividends
Yield
—
Payout
71.44%
DPS
$2.97
DPS Growth 3Yr
1.98%
DPS Growth 5Yr
1.19%
DPS Growth 10Yr
0.59%
DPS Growth Fwd 2Yr
5.85%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)